We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGS icon
2776
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.77B
$566K ﹤0.01%
14,205
+352
+3% +$15.5K
RC
2777
Ready Capital
RC
$289M
$566K ﹤0.01%
55,857
-1,683
-3% -$21.8K
GVIP icon
2778
Goldman Sachs Hedge Industry VIP ETF
GVIP
$584M
$563K ﹤0.01%
8,195
-587
-7% -$44.2K
BCV
2779
Bancroft Fund
BCV
$144M
$562K ﹤0.01%
33,599
-4,760
-12% -$90.3K
TTP
2780
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
$562K ﹤0.01%
22,482
-1,334
-6% -$37.5K
SPTL icon
2781
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
$561K ﹤0.01%
+18,920
New +$614K
BBWI icon
2782
Bath & Body Works
BBWI
$3.76B
$559K ﹤0.01%
17,136
+5,639
+49% +$199K
DNA icon
2783
Ginkgo Bioworks
DNA
$488M
$559K ﹤0.01%
4,479
+1,466
+49% +$175K
PAGS icon
2784
PagSeguro Digital
PAGS
$2.4B
$558K ﹤0.01%
42,202
+19,593
+87% +$262K
SOFI icon
2785
PUT
SoFi Technologies
SOFI
$23.8B
$558K ﹤0.01%
+754,000
New +$4.77M
CORP icon
2786
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
$557K ﹤0.01%
6,100
-2,628
-30% -$253K
CCCC icon
2787
C4 Therapeutics
CCCC
$502M
$556K ﹤0.01%
63,432
+34,390
+118% +$357K
XRX icon
2788
Xerox
XRX
$412M
$556K ﹤0.01%
42,517
+6,775
+19% +$110K
RYTM icon
2789
Rhythm Pharmaceuticals
RYTM
$8.1B
$554K ﹤0.01%
+22,600
New +$420K
ALKS icon
2790
Alkermes
ALKS
$8.44B
$553K ﹤0.01%
24,766
-2,220
-8% -$57.7K
CLOU icon
2791
Global X Cloud Computing ETF
CLOU
$281M
$553K ﹤0.01%
34,643
-10,452
-23% -$181K
BWX icon
2792
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$552K ﹤0.01%
26,482
-761
-3% -$17.2K
PACB icon
2793
Pacific Biosciences
PACB
$357M
$552K ﹤0.01%
95,090
+1,365
+1% +$7.83K
FIZZ icon
2794
National Beverage
FIZZ
$2.9B
$551K ﹤0.01%
+14,297
New +$715K
FDVV icon
2795
Fidelity High Dividend ETF
FDVV
$10.5B
$549K ﹤0.01%
16,623
-4,966
-23% -$185K
ERO icon
2796
Ero Copper
ERO
$3.58B
$548K ﹤0.01%
49,805
+2,000
+4% +$19.5K
GPMT
2797
Granite Point Mortgage Trust
GPMT
$58.8M
$548K ﹤0.01%
85,059
+952
+1% +$9.02K
DTD icon
2798
WisdomTree US Total Dividend Fund
DTD
$1.7B
$547K ﹤0.01%
10,084
+3,600
+56% +$214K
IEV icon
2799
iShares Europe ETF
IEV
$1.7B
$547K ﹤0.01%
14,487
-157
-1% -$6.64K
OUT icon
2800
Outfront Media
OUT
$5.29B
$546K ﹤0.01%
36,518
+3,743
+11% +$66K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.